Omega Healthcare Investors, Inc. (NYSE:OHI) Position Increased by International Assets Investment Management LLC

International Assets Investment Management LLC lifted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 3,613.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 157,552 shares of the real estate investment trust’s stock after purchasing an additional 153,309 shares during the quarter. International Assets Investment Management LLC owned 0.06% of Omega Healthcare Investors worth $6,412,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in OHI. Plan Group Financial LLC grew its holdings in Omega Healthcare Investors by 10.3% during the third quarter. Plan Group Financial LLC now owns 23,158 shares of the real estate investment trust’s stock valued at $943,000 after purchasing an additional 2,167 shares during the last quarter. Rainey & Randall Investment Management Inc. lifted its position in Omega Healthcare Investors by 2.9% in the third quarter. Rainey & Randall Investment Management Inc. now owns 176,978 shares of the real estate investment trust’s stock worth $7,203,000 after purchasing an additional 5,024 shares during the period. Private Advisor Group LLC lifted its position in Omega Healthcare Investors by 6.3% in the third quarter. Private Advisor Group LLC now owns 27,971 shares of the real estate investment trust’s stock worth $1,138,000 after purchasing an additional 1,662 shares during the period. Foundations Investment Advisors LLC lifted its position in Omega Healthcare Investors by 52.1% in the third quarter. Foundations Investment Advisors LLC now owns 22,650 shares of the real estate investment trust’s stock worth $922,000 after purchasing an additional 7,755 shares during the period. Finally, Bellecapital International Ltd. bought a new position in shares of Omega Healthcare Investors during the third quarter valued at $212,000. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Trading Down 0.2 %

Shares of OHI stock opened at $42.43 on Friday. The stock has a market cap of $10.94 billion, a price-to-earnings ratio of 31.20, a PEG ratio of 1.34 and a beta of 1.00. The stock has a 50-day moving average of $40.42 and a 200-day moving average of $35.89. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). The company had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The company’s quarterly revenue was up 17.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.74 EPS. On average, equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be paid a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.32%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on OHI shares. Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. BMO Capital Markets boosted their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Scotiabank lifted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Mizuho cut Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their target price for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Finally, Berenberg Bank began coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $39.70.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.